1 / 16

Community Acquired Pneumonia

Community Acquired Pneumonia. CAP - Bugs. * Influenza A and B, adenovirus, respiratory syncytial virus, and parainfluenza. CAP- epidemiologic considerations. CAP – Clinical Features. Productive cough Fever Pleuritic chest pain Dyspnea GI symptoms Mental status changes.

conner
Télécharger la présentation

Community Acquired Pneumonia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Community Acquired Pneumonia

  2. CAP - Bugs *Influenza A and B, adenovirus, respiratory syncytial virus, and parainfluenza.

  3. CAP- epidemiologic considerations

  4. CAP – Clinical Features • Productive cough • Fever • Pleuritic chest pain • Dyspnea • GI symptoms • Mental status changes

  5. CAP - Physical Exam Findings • Febrile • RR >24 breaths/minute • Tachycardia • Rales • +egophany

  6. CAP - Diagnosis • Chest Xray with infiltrate • Leukocytosis • Blood cultures • Sputum – gram stain and culture • Urine antigens • Influenza testing • Viral culture • ABG **If hospitalized within last 90 days or if lives at ECF, received outpatient dialysis then patient would be considered as hospital or healthcare associated pneumonia

  7. CAP - Admit or Not? • Severity Scores • CURB-65 • PSI = Pneumonia Severity Index • Helps to determine severity of illness • Helps to determine if patient should be admitted and whether needs admitted to ICU

  8. CAP - CURB 65 • Confusion • Urea (BUN >20mg/dL) • Respiratory Rate > 30 breaths/minute • Blood Pressure (systolic <90mmHg or diastolic <60mmHg) • Age >65 years * 1 point for each

  9. CAP – CURB65

  10. CAP - PSI

  11. CAP - PSI

  12. CAP – Inpatient Treatment

  13. CAP – Inpatient Treatment • Suspected MRSA- add vancomycin or linezolid • Suspected aspiration- ertapenem or moxifloxacin • *Pseudomonal risk factors = • Bronchiectasis documented on admission • Structural lung disease and h/o pneumonias or chronic steroid use

  14. CAP – Inpatient Treatment • Switch to Oral Therapy • When clinically improving, hemodynamically stable, able to take oral meds • Duration of Hospitalization • Several studies support that it is not necessary to observe pt overnight after change to PO antibiotics • Consider discharge after no signs of clinical instability which is defined as: Temp >100, RR>24, SBP <90, HR>100, O2 sat <90, altered mental status, inability to take PO • Duration of Treatment • Minimum of 5 days (most treat 7-14 days) • Before consideration of discontinuing abx need to have: • Afebrile for 48-72 hours • No supplemental O2 • No signs of clinical instability

  15. CAP – Follow Up Recs • When should you get a follow up CXR? • No clear evidence • Most recommend f/u CXR for patients >40 years and h/o smoking to document resolution of disease and no underlying malignancy • Obtain CXR 7-12 weeks after completion of treatment

  16. CAP Quality Measures • Blood cultures prior to first antibiotic dose • Oxygen assessment • Initial antibiotics within 6 hours of presentation • Appropriate antibiotic selection • Pneumococcal vaccine for pts >65 • Influenza vaccine for pts >50 during Oct-March • Smoking cessation counseling

More Related